Hepatology

A recent study demonstrates hepatocellular carcinoma screening in patients with liver disease and cirrhosis to be associated with improved early-stage tumour detection and survival, persisting after lead-time and length-time bias adjustment.

A new research from the University of Hong Kong has identified bone mineral density as a potentially novel risk factor and early predictor for cirrhosis development. Read more.

Exploring strategies to optimise outcomes for those with HAAA, and assessing both safety and efficacy of HSCT was the goal of an emerging piece of research.

According to research, dietary acid load is significantly associated with cirrhosis-related mortality, and there is further need of investigating underlying mechanisms, as well as establishing optimal DAL levels in patients with cirrhosis.

Screening for osteoporosis is considerably lower in patients with cirrhosis compared with the general population, and less than 25% of those with low bone density are treated, according to a recent study. Read more.

Male hypogonadism is associated with visceral obesity and metabolic syndrome. The present study aims to compare the effects of testosterone treatment with a placebo in treating non-alcoholic fatty liver disease in older hypogonadal males.

New data suggests that the risk of alcoholic relapse in patients with alcohol-related liver disease who underwent liver transplant may be more accurately determined with the help of a new scoring system.

Waitlist outcomes are improved by living donor liver transplantation for high-risk patients with cirrhosis, according to a recent study. This study aimed to assess the impact of access to LDLT in waitlisted patients at highest risk of dropout.